A Phase 1 Dose-Escalation Study of Oral ARRY-438162 in Patients With Advanced Solid Tumors Followed by an Expansion Cohort in Patients With Advanced or Metastatic Biliary Cancer.
Phase of Trial: Phase I
Latest Information Update: 02 Feb 2017
At a glance
- Drugs Binimetinib (Primary)
- Indications Biliary cancer; Colorectal cancer; Solid tumours
- Focus Adverse reactions; Pharmacokinetics
- 02 Feb 2017 Results published in the British Journal of Cancer
- 01 Jan 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 11 May 2012 Status changed from recruiting to active, no longer recruiting as reported by M.D. Anderson Cancer Center record.